ask="N/A"
ask_size="N/A"
average_daily_volume="247150"
bid="5.15"
bid_size="100"
book_value="3.42"
change="-0.06"
change_from_200_day_moving_average="-0.26"
change_from_50_day_moving_average="0.19"
change_from_52_week_high="-4.59"
change_From_52_week_low="2.32"
change_in_percent="-0.75%"
close="7.91"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.07"
ebitda="-1.40M"
eps_estimate_current_year="-2.94"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-2.63"
ex_dividend_date="N/A"
float_shares="5020000"
high="7.99"
high_52_weeks="12.50"
last_trade_date="2/15/2017"
last_trade_price="7.91"
last_trade_size="200"
last_trade_time="4:00pm"
low="7.77"
low_52_weeks="5.59"
market_capitalization="96.21M"
moving_average_200_day="8.17"
moving_average_50_day="7.72"
name="Recro Pharma
Inc."
notes="N/A"
one_year_target_price="20.80"
open="7.99"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-3.17%"
percent_change_from_50_day_moving_average="+2.47%"
percent_change_from_52_week_high="-36.72%"
percent_change_from_52_week_low="+41.50%"
previous_close="7.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.33"
price_per_sales="1.41"
revenue="68.73M"
shares_outstanding="12163000"
short_ratio="3.68"
stock_exchange="NCM"
symbol="REPH"
volume="61711"
weeks_range_52="5.59 - 12.50"
